References
- 1Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 2001; 29(1): 66–9. DOI: 10.1038/ng709
- 2Timmers ER, Smit M, Kuiper A, Bartels AL, van der Veen S, van der Stouwe AMM, et al. Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes. Parkinsonism & related disorders. 2019; 69: 85–90. DOI: 10.1016/j.parkreldis.2019.10.015
- 3Peall KJ, Dijk JM, Saunders-Pullman R, Dreissen YE, van Loon I, Cath D, et al. Psychiatric disorders, myoclonus dystonia and SGCE: an international study. Ann Clin Transl Neurol. 2016; 3(1): 4–11. DOI: 10.1002/acn3.263
- 4Raymond D, Saunders-Pullman R, de Carvalho Aguiar P, Schule B, Kock N, Friedman J, et al. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. Movement disorders: official journal of the Movement Disorder Society. 2008; 23(4): 588–92. DOI: 10.1002/mds.21785
- 5Chen XP, Zhang YW, Zhang SS, Chen Q, Burgunder JM, Wu SH, et al. A novel mutation of the epsilon-sarcoglycan gene in a Chinese family with myoclonus-dystonia syndrome. Movement disorders: official journal of the Movement Disorder Society. 2008; 23(10): 1472–5. DOI: 10.1002/mds.22008
- 6Borges V, Aguiar Pde C, Ferraz HB, Ozelius LJ. Novel and de novo mutations of the SGCE gene in Brazilian patients with myoclonus-dystonia. Movement disorders: official journal of the Movement Disorder Society. 2007; 22(8): 1208–9. DOI: 10.1002/mds.21380
- 7Rachad L, El Otmani H, Karkar A, El Moutawakil B, El Kadmiri N, Nadifi S. Screening for SGCE mutations in Moroccan sporadic patients with Myoclonus-Dystonia syndrome. Neuroscience letters. 2019; 703: 1–4. DOI: 10.1016/j.neulet.2019.03.003
- 8Jain P, Sharma S, van Ruissen F, Aneja S. Myoclonus-dystonia: An under-recognized entity – Report of 5 cases. Neurol India. 2016; 64(5): 980–3. DOI: 10.4103/0028-3886.190255
- 9Thummler S, Giuliano F, Pincemaille O, Saugier-Veber P, Perelman S. Myoclonus in fraternal twin toddlers: a French family with a novel mutation in the SGCE gene. Eur J Paediatr Neurol. 2009; 13(6): 559–61. DOI: 10.1016/j.ejpn.2008.11.009
- 10Nardocci N. Myoclonus-dystonia syndrome. Handb Clin Neurol. 2011; 100: 563–75. DOI: 10.1016/B978-0-444-52014-2.00041-0
- 11Chung EJ, Lee WY, Kim JY, Kim JH, Kim GM, Ki CS, et al. Novel SGCE gene mutation in a Korean patient with myoclonus-dystonia with unique phenotype mimicking Moya-Moya disease. Movement disorders: official journal of the Movement Disorder Society. 2007; 22(8): 1206–7. DOI: 10.1002/mds.21093
- 12Marras C, Van den Eeden SK, Fross RD, Benedict-Albers KS, Klingman J, Leimpeter AD, et al. Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology. 2007; 69(7): 676–80. DOI: 10.1212/01.wnl.0000267425.51598.c9
- 13Defazio G, Jankovic J, Giel JL, Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. DOI: 10.5334/tohm.170
- 14Gatto EM, Pardal MM, Micheli FE. Unusual phenotypic expression of the DYT1 mutation. Parkinsonism & related disorders. 2003; 9(5): 277–9. DOI: 10.1016/S1353-8020(02)00128-1
- 15Park J, Damrauer SM, Baras A, Reid JG, Overton JD, Gonzalez-Alegre P. Epidemiology of DYT1 dystonia: Estimating prevalence via genetic ascertainment. Neurology Genetics. 2019; 5(5):
e358 . DOI: 10.1212/NXG.0000000000000358 - 16Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014; 46(3): 310–5. DOI: 10.1038/ng.2892
- 17Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic acids research. 2019; 47(D1): D886–D94. DOI: 10.1093/nar/gky1016
- 18Liu X, Wu C, Li C, Boerwinkle E. dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs. Hum Mutat. 2016; 37(3): 235–41. DOI: 10.1002/humu.22932
- 19Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. American journal of human genetics. 2016; 99(4): 877–85. DOI: 10.1016/j.ajhg.2016.08.016
- 20Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Human molecular genetics. 2015; 24(8): 2125–37. DOI: 10.1093/hmg/ddu733
- 21Schule B, Kock N, Svetel M, Dragasevic N, Hedrich K, De Carvalho Aguiar P, et al. Genetic heterogeneity in ten families with myoclonus-dystonia. Journal of neurology, neurosurgery, and psychiatry. 2004; 75(8): 1181–5. DOI: 10.1136/jnnp.2003.027177
- 22Tezenas du Montcel S, Clot F, Vidailhet M, Roze E, Damier P, Jedynak CP, et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet. 2006; 43(5): 394–400. DOI: 10.1136/jmg.2005.036780
- 23Peall KJ, Kurian MA, Wardle M, Waite AJ, Hedderly T, Lin JP, et al. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. Journal of neurology. 2014; 261(12): 2296–304. DOI: 10.1007/s00415-014-7488-3
- 24Xiao J, Nance MA, LeDoux MS. Incomplete nonsense-mediated decay facilitates detection of a multi-exonic deletion mutation in SGCE. Clinical genetics. 2013; 84(3): 276–80. DOI: 10.1111/cge.12059
- 25Sundaram L, Gao H, Padigepati SR, McRae JF, Li Y, Kosmicki JA, et al. Predicting the clinical impact of human mutation with deep neural networks. Nat Genet. 2018; 50(8): 1161–70. DOI: 10.1038/s41588-018-0167-z
- 26Varga MG, Nand NP, LeDoux MS. Delayed diagnoses of SGCE myoclonus-dystonia. Tremor Other Hyperkinet Mov (N Y). 2020. DOI: 10.5334/tohm.334
- 27Winder TL, Tan CA, Klemm S, White H, Westbrook JM, Wang JZ, et al. Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders. Neurology Genetics. 2020; 6(2):
e412 . DOI: 10.1212/NXG.0000000000000412
DOI: https://doi.org/10.5334/tohm.567 | Journal eISSN: 2160-8288
Language: English
Submitted on: Sep 6, 2020
Accepted on: Oct 25, 2020
Published on: Nov 4, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2020 Mark S. LeDoux, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.